Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 9.01 · 8-K

Aetherium Acquisition Corp.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, on November 14, 2024, Mariana Kou and Charles Abelmann each resigned as independent directors of the Board of Directors (the “Board”) of Aetherium Acquisition Corp. (the “Company”). Ms. Kou and Mr.…

Filed Jul 23, 2025Accepted Jul 23, 2025, 5:21 AM EDTCIK 1866547Accession 0001641172-25-020660
Share

Company context

Historical securities (3)

Recent company filings

  1. PRE 14A filingMar 16, 2026
  2. 25-NSE - filed by Nasdaq Stock Market LLC regarding Aetherium Acquisition CorpAug 8, 2025
  3. 10-Q filingJul 31, 2025
  4. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security HoldersJul 11, 2025
  5. DEFA14A filingJun 26, 2025

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed, on November 14, 2024, Mariana Kou and Charles Abelmann each resigned as independent directors of the Board of Directors (the “Board”) of Aetherium Acquisition Corp. (the “Company”). Ms. Kou and Mr. Abelmann’s resignations were for personal reasons and did not result from any disagreement with the Company on any matter relating to its operations, policies, or practices, including with respect to accounting principles or practices, financial statement disclosure, or internal controls. On July 21, 2025, three new independent directors were appointed by the Board and the Company’s audit committee. The Board has determined that each of the new independent directors meet the heightened independence standards for service on the audit committee set forth in Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended. No family relationships exist between any of the new independent directors and the Company’s directors or executive officers. There is no arrangement or understanding between any of the new independent directors and any other persons pursuant to which they were selected as directors. On July 23, 2025, the Company entered into an indemnity agreement (the “Indemnity Agreement”) with each of the new independent directors, pursuant to which the Company has agreed to provide contractual indemnification, in addition to the indemnification provided in the Company’s Amended and Restated Certificate of Incorporation, against liabilities that may arise by reason of his respective service on the Board, and to advance expenses incurred as a result of any proceeding against him as to which he could be indemnified, in the form previously executed with its other directors and officers. On July 23, 2025, each of the new independent directors joined the letter agreement, dated December 29, 2021, by and among the Company, the Company’s sponsor, Aetherium Capital Holdings LLC (the “Sponsor”), and its directors and officers (the “Letter Agreement”) by entering into a joinder to the Letter Agreement. On July 23, 2025, the Company and each of the new independent directors entered into a joinder to the registration rights agreement, dated December 29, 2021, entered into by and between the Company and each of its other directors and the other parties thereto in connection with the Company’s public offering (the “Registration Rights Agreement”). The foregoing descriptions of the Indemnity Agreement, the Letter Agreement and the Registration Rights Agreement do not purport to be complete and are qualified in their entireties by reference to the form of indemnity agreement, the Letter Agreement and the Registration Rights Agreement, copies of which are attached as Exhibit 10.1, Exhibit 10.2 and Exhibit 10.3 hereto, respectively, and are incorporated herein by reference. Other than as disclosed above, there are no related party transactions involving any of the new independent directors that are reportable under Item 404(a) of Regulation S-K. In connection with his appointment as a director of the Company, each of the new independent directors will in due course receive 30,000 founder shares from the Sponsor, while our continuing independent director Lim How Teck will in due course receive an additional 20,000 founder shares from the Sponsor. The three new independent directors are: Jeffrey Chi, Ph. D. is a veteran in the venture capital industry and a strong advocate for the promotion of venture capital, entrepreneurship & socially responsible investing. Dr. Chi has served as the Chairman of the board of directors of Vickers Vantage Corp. I and its Chief Executive Officer from February 2020 to November 2022. The SPAC was successfully consummated and Dr. Chi currently serves as an independent director of Aardvark Therapeutics (AARD). Dr. Chi co-founded Vickers Ventures Partners in 2005, and serves as its Vice Chairman and a member of its board of directors and Investment Committee. From 2013 to April 2017, Dr. Chi also served as the Chairman of the Singapore Venture Capital and Private Equity Association. From 2001 to 2005, Dr. Chi initially served as a Senior Consultant with the Monitor Group and later served as Executive Director with Pegasus Capital. Dr. Chi also sits on an advisory panel of the Monetary Authority of Singapore and previously sat on the board of SEEDS Capital (the investment arm of Enterprise Singapore) as well as on the advisory panels ETLP (the commercialization arm of A*Star) and the National University of Singapore Department of Industrial Systems Engineering and Management. Based out of Shanghai, Dr. Chi heads Vickers Venture’s investments in Asia and has investments in artificial intelligence, education, healthcare/wellness and financial services (including fintech) technology companies. Prior to managing venture capital funds, Dr. Chi managed advisory engagements for a wide range of clients in both the public and private sectors. Dr. Chi’s operational background includes working on the management team of an engineering and construction group where he oversaw operations in Singapore, Malaysia, Taiwan and Indonesia. Dr. Chi also serves as a member of the board of directors of Vivance Pte Ltd (a renal care company), Jing-jin Electric Technologies Co., Ltd. (SH: 668280) and MatchMove Pay Pte. Ltd. Dr. Chi received his Ph. D. from the Massachusetts Institute of Technology in systems engineering, his M.A. from the University of Cambridge in engineering, his S.M. from the Massachusetts Institute of Technology in engineering and his B.A. from the University of Cambridge in engineering. He is also a C.F.A. charterholder, and is fluent in English and Mandarin. We believe Dr. Chi is qualified to serve on our board of directors because of his experience, relationships and contacts, combined with his experience serving on the boards of directors of successful, high-growth public and private companies. Ling Yew Kong is a seasoned private equity investor and corporate executive with over 30 years of expertise spanning mergers and acquisitions, accounting and finance, securities operations, treasury management, infrastructure development, and corporate restructuring. Mr. Ling began his career at Ernst & Young as an Audit Assistant (1991-1993) before transitioning to progressively senior roles in securities and investment management. His career trajectory includes Finance Manager at Keppel Securities Pte Ltd (1993-1994), Vice President at Deutsche Morgan Grenfell & Partners Securities Pte Ltd (1994-1996), Head of Sales at SocGen Crosby Securities Pte Ltd (1996-1998), and Vice President at BT Brokerage & Associates Pte Ltd (1999-2000). Mr. Ling currently serves as Executive Chairman & Managing Director of Singapore based First Link Investments Corporation Limited and Director of Eternal Asia New Energy Technology Pte Ltd. He also chairs multiple companies across Singapore and Malaysia, including Alphasky Group Limited (BVI), Terra Pontus Pte. Ltd., and One Way Investment Pte. Ltd., where he provides strategic guidance and charts growth directions. Mr. Ling brings substantial public company expertise, having served in executive and board positions at several listed entities, including CEO & Executive Director of China Sky Chemical Fibre Co., Ltd, Chairman & Director of Moya Holdings Asia Ltd, COO & Executive Director of IPCO International Ltd, and director roles at SBI Offshore Limited, Anwell Technologies Limited, and Metronic Global Berhad. Mr. Ling holds a Bachelor of Commerce degree with a major in Accounting from Murdoch University, Western Australia, and is a member of the Australian Society of Certified Practicing Accountants. Mr. Ling’s extensive industry experience, valuable professional relationships, and proven track record serving on the boards of successful, high-growth companies make him exceptionally qualified to join our board of directors. Shantanu Jha is the Chief Investment Officer of Beaconsfield Capital Management, a multi-strategy, technology-focused investment manager that he co-founded in 2014. He led its quantitative trading division before overseeing investments in semiconductors, defense technology, and biotechnology, including rounds in Lightmatter, Anduril, and Figure AI. Since 2023, he has served as the founder, Chairman, and CEO of Yliastrum Ltd, the holding company for the Xynon technology platform, which supports pension funds, provident funds, and superannuation in Australasia. Concurrently, he serves as Executive Chairman of Morrison Securities, Australia’s second-largest exchange clearing participant and largest retail options broker. Since 2022, he has served as a director and co-founder of Pinewood Energy, focusing on the development of an 800 MW distributed solar energy grid in Maharashtra, India. From 2017 to 2020, he served as co-founder and CTO of Vahan AI, a Boston-based sensor fusion firm, and led its exit via a strategic sale. Mr. Jha has served as a director of the India Japan Foundation since January 2022 and received the An Jong Geun Award in Seoul in April 2023 by the Former Defence Minister of the Armed Forces of Korea for his efforts in delivering education technology to underprivileged communities in Asia. We believe Mr. Jha is qualified to serve on our board of directors because of his experience, relationships, and contacts, combined with his experience serving on the boards of directors of successful, high-growth companies.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.